Difference between revisions of "Chordoma"

Jump to navigation Jump to search
559 bytes added ,  17:13, 14 January 2016
Line 104: Line 104:
**CK7 -ve (1 +ve/16).
**CK7 -ve (1 +ve/16).
**CK20 -ve (0 +ve/16).
**CK20 -ve (0 +ve/16).
Classic chordoma panel:<ref name=pmid24296480>{{Cite journal  | last1 = Shen | first1 = J. | last2 = Shi | first2 = Q. | last3 = Lu | first3 = J. | last4 = Wang | first4 = DL. | last5 = Zou | first5 = TM. | last6 = Yang | first6 = HL. | last7 = Zhu | first7 = GQ. | title = Histological study of chordoma origin from fetal notochordal cell rests. | journal = Spine (Phila Pa 1976) | volume = 38 | issue = 25 | pages = 2165-70 | month = Dec | year = 2013 | doi = 10.1097/BRS.0000000000000010 | PMID = 24296480 }}</ref>
*EMA, AE1/AE3, CAM5.2, vimentin, S-100.


Key points:   
Key points:   
*Brachyury is not a commonly stocked antibody.
*Brachyury is not a commonly stocked antibody.
*Chordoma will be S100 '''AND''' Epithelial marker positive.   
*Chordoma will be S100 '''AND''' epithelial marker positive.   
*Many other items in the DDX will be either S100 '''OR''' Epithelial marker positive.
*Many other items in the DDx will be either S100 '''OR''' epithelial marker positive.


==See also==
==See also==
48,836

edits

Navigation menu